Skip to main content

Military Health System

Utility Navigation Links

WEEKEND MAINTENANCE: The maintenance outage is scheduled for June 22nd at 6:00am EST ending NLT Sunday, June 23rd at 11:59pm Eastern EST. The TRICARE Manuals web site may be available intermittently during this period but it's usage is not recommended.

TRICARE Policy Manual 6010.60-M, April 1, 2015
Other Services
Chapter 8
Section 2.5
Home Prothrombin Time (PT) International Normalized Ratio (INR) Monitor
Issue Date:  March 3, 2005
Revision:  
1.0  HCPCS PROCEDURE CODES
G0248, G0249, G0250
2.0  DESCRIPTION
Home PT INR monitoring devices are portable, battery-operated, hand-held analyzing systems designed for testing a small sample of fresh, capillary whole blood obtained by a finger-stick using a lancet device. Depending on the system, the drop of blood is placed on a test strip or disposable reagent cuvette. A new test strip or reagent cartridge must be used with each test performed. Once clotting is initiated, PT is determined by different ways depending on the device:
•  By cessation of blood flow;
•  By changes in light transmission;
•  Through use of fluorescent thrombin substrate.
3.0  POLICY
3.1  Home PT INR monitors may be covered for patients meeting the following criteria:
3.1.1  The patient must have a medical condition requiring lifetime warfarin therapy and monitoring of prothrombin time activity.
3.1.2  The patient must need to have frequent prothrombin time testing once a week or multiple times per month.
3.1.3  The patient (or patient’s caregiver) must have the ability to use the prothrombin time monitoring device after obtaining education on its proper use from an appropriate health care professional.
3.2  The monitor must be prescribed by a physician.
3.3  The device must have U.S. Food and Drug Administration (FDA) approval.
3.4  Related services and supplies, such as PT test strips and office visits, are covered.
3.5  Education or demonstration related to the use of the device is considered incidental to the office visit or the provision of the materials and equipment. Additional reimbursement is not warranted.
4.0  EFFECTIVE DATE
Date of FDA approval of the device.
- END -
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery